Table 1 Clinical and pathological characteristics of gastric cancer patients without LVI

n

1475

Sex (%)

 Male

1060 (71.9)

 Female

415 (28.1)

Age (median [IQR])

59.00 [52.00, 65.00]

pTNM (%)

 I

487 (33.0)

 II

487 (33.0)

 III

462 (31.3)

 IV

39 (2.6)

Borrmann (%)

 0

347 (23.5)

 I

52 (3.5)

 II

279 (18.9)

 III

713 (48.3)

 IV

84 (5.7)

Lauren (%)

 Intestinal

700 (47.5)

 Diffuse

544 (36.9)

 Mixed

231 (15.7)

Location (%)

 Low

995 (67.5)

 Middle

298 (20.2)

 Upper

137 (9.3)

 Whole

45 (3.1)

 Tumor size (median [IQR])

40.00 [25.00, 55.00]

 LMR (median [IQR])

4.30 [3.23, 5.55]

 PLR (median [IQR])

124.74 [95.93, 164.38]

 NLR (median [IQR])

1.88 [1.39, 2.55]

 PNI (median [IQR])

50.90 [46.85, 54.77]

 APRI (median [IQR])

0.08 [0.06, 0.12]

 AAR (median [IQR])

1.10 [0.89, 1.33]

 LAR (median [IQR])

3.86 [3.42, 4.32]

 DIR (median [IQR])

0.55 [0.45, 0.67]

 FLR (median [IQR])

1.45 [1.11, 1.96]

 CEA (median [IQR])

2.06 [1.24, 3.38]

 CA199 (median [IQR])

10.06 [5.99, 17.62]

 CA724 (median [IQR])

2.35 [1.32, 5.16]

 CA125 (median [IQR])

9.69 [7.37, 13.33]